Report Detail
Global Personalized Medicine for Cancer Market Growth (Status and Outlook) 2022-2028
- RnM4458672 |
- 28 June, 2022 |
- Global |
- 101 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
As the global economy mends, the 2021 growth of Personalized Medicine for Cancer will have significant change from previous year. According to our (LP Information) latest study, the global Personalized Medicine for Cancer market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Personalized Medicine for Cancer market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Personalized Medicine for Cancer market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Personalized Medicine for Cancer market, reaching US$ million by the year 2028. As for the Europe Personalized Medicine for Cancer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Personalized Medicine for Cancer players cover Bayer, GlaxoSmithKline, Novartis, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Personalized Medicine for Cancer market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Immunotherapy
Targeted Therapy
Chemotherapy
Hormone Therapy
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Breast Cancer
Blood Cancer
Gastrointestinal Cancer
Prostate Cancer
Skin Cancer
Lung Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Merck
Bristol-Myers Squibb
Ariad Pharmaceuticals (Takeda)
Eli Lilly
Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Personalized Medicine for Cancer Market Size 2017-2028
- 2.1.2 Personalized Medicine for Cancer Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Personalized Medicine for Cancer Segment by Type
- 2.2.1 Immunotherapy
- 2.2.2 Targeted Therapy
- 2.2.3 Chemotherapy
- 2.2.4 Hormone Therapy
- 2.2.5 Others
- 2.3 Personalized Medicine for Cancer Market Size by Type
- 2.3.1 Personalized Medicine for Cancer Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Personalized Medicine for Cancer Market Size Market Share by Type (2017-2022)
- 2.4 Personalized Medicine for Cancer Segment by Application
- 2.4.1 Breast Cancer
- 2.4.2 Blood Cancer
- 2.4.3 Gastrointestinal Cancer
- 2.4.4 Prostate Cancer
- 2.4.5 Skin Cancer
- 2.4.6 Lung Cancer
- 2.4.7 Others
- 2.5 Personalized Medicine for Cancer Market Size by Application
- 2.5.1 Personalized Medicine for Cancer Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Personalized Medicine for Cancer Market Size Market Share by Application (2017-2022)
3 Personalized Medicine for Cancer Market Size by Player
- 3.1 Personalized Medicine for Cancer Market Size Market Share by Players
- 3.1.1 Global Personalized Medicine for Cancer Revenue by Players (2020-2022)
- 3.1.2 Global Personalized Medicine for Cancer Revenue Market Share by Players (2020-2022)
- 3.2 Global Personalized Medicine for Cancer Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Personalized Medicine for Cancer by Regions
- 4.1 Personalized Medicine for Cancer Market Size by Regions (2017-2022)
- 4.2 Americas Personalized Medicine for Cancer Market Size Growth (2017-2022)
- 4.3 APAC Personalized Medicine for Cancer Market Size Growth (2017-2022)
- 4.4 Europe Personalized Medicine for Cancer Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Personalized Medicine for Cancer Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Personalized Medicine for Cancer Market Size by Country (2017-2022)
- 5.2 Americas Personalized Medicine for Cancer Market Size by Type (2017-2022)
- 5.3 Americas Personalized Medicine for Cancer Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Personalized Medicine for Cancer Market Size by Region (2017-2022)
- 6.2 APAC Personalized Medicine for Cancer Market Size by Type (2017-2022)
- 6.3 APAC Personalized Medicine for Cancer Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Personalized Medicine for Cancer by Country (2017-2022)
- 7.2 Europe Personalized Medicine for Cancer Market Size by Type (2017-2022)
- 7.3 Europe Personalized Medicine for Cancer Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Personalized Medicine for Cancer by Region (2017-2022)
- 8.2 Middle East & Africa Personalized Medicine for Cancer Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Personalized Medicine for Cancer Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Personalized Medicine for Cancer Market Forecast
- 10.1 Global Personalized Medicine for Cancer Forecast by Regions (2023-2028)
- 10.1.1 Global Personalized Medicine for Cancer Forecast by Regions (2023-2028)
- 10.1.2 Americas Personalized Medicine for Cancer Forecast
- 10.1.3 APAC Personalized Medicine for Cancer Forecast
- 10.1.4 Europe Personalized Medicine for Cancer Forecast
- 10.1.5 Middle East & Africa Personalized Medicine for Cancer Forecast
- 10.2 Americas Personalized Medicine for Cancer Forecast by Country (2023-2028)
- 10.2.1 United States Personalized Medicine for Cancer Market Forecast
- 10.2.2 Canada Personalized Medicine for Cancer Market Forecast
- 10.2.3 Mexico Personalized Medicine for Cancer Market Forecast
- 10.2.4 Brazil Personalized Medicine for Cancer Market Forecast
- 10.3 APAC Personalized Medicine for Cancer Forecast by Region (2023-2028)
- 10.3.1 China Personalized Medicine for Cancer Market Forecast
- 10.3.2 Japan Personalized Medicine for Cancer Market Forecast
- 10.3.3 Korea Personalized Medicine for Cancer Market Forecast
- 10.3.4 Southeast Asia Personalized Medicine for Cancer Market Forecast
- 10.3.5 India Personalized Medicine for Cancer Market Forecast
- 10.3.6 Australia Personalized Medicine for Cancer Market Forecast
- 10.4 Europe Personalized Medicine for Cancer Forecast by Country (2023-2028)
- 10.4.1 Germany Personalized Medicine for Cancer Market Forecast
- 10.4.2 France Personalized Medicine for Cancer Market Forecast
- 10.4.3 UK Personalized Medicine for Cancer Market Forecast
- 10.4.4 Italy Personalized Medicine for Cancer Market Forecast
- 10.4.5 Russia Personalized Medicine for Cancer Market Forecast
- 10.5 Middle East & Africa Personalized Medicine for Cancer Forecast by Region (2023-2028)
- 10.5.1 Egypt Personalized Medicine for Cancer Market Forecast
- 10.5.2 South Africa Personalized Medicine for Cancer Market Forecast
- 10.5.3 Israel Personalized Medicine for Cancer Market Forecast
- 10.5.4 Turkey Personalized Medicine for Cancer Market Forecast
- 10.5.5 GCC Countries Personalized Medicine for Cancer Market Forecast
- 10.6 Global Personalized Medicine for Cancer Forecast by Type (2023-2028)
- 10.7 Global Personalized Medicine for Cancer Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Bayer
- 11.1.1 Bayer Company Information
- 11.1.2 Bayer Personalized Medicine for Cancer Product Offered
- 11.1.3 Bayer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Bayer Main Business Overview
- 11.1.5 Bayer Latest Developments
- 11.2 GlaxoSmithKline
- 11.2.1 GlaxoSmithKline Company Information
- 11.2.2 GlaxoSmithKline Personalized Medicine for Cancer Product Offered
- 11.2.3 GlaxoSmithKline Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 GlaxoSmithKline Main Business Overview
- 11.2.5 GlaxoSmithKline Latest Developments
- 11.3 Novartis
- 11.3.1 Novartis Company Information
- 11.3.2 Novartis Personalized Medicine for Cancer Product Offered
- 11.3.3 Novartis Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Novartis Main Business Overview
- 11.3.5 Novartis Latest Developments
- 11.4 Sanofi
- 11.4.1 Sanofi Company Information
- 11.4.2 Sanofi Personalized Medicine for Cancer Product Offered
- 11.4.3 Sanofi Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Sanofi Main Business Overview
- 11.4.5 Sanofi Latest Developments
- 11.5 Pfizer
- 11.5.1 Pfizer Company Information
- 11.5.2 Pfizer Personalized Medicine for Cancer Product Offered
- 11.5.3 Pfizer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Pfizer Main Business Overview
- 11.5.5 Pfizer Latest Developments
- 11.6 Amgen
- 11.6.1 Amgen Company Information
- 11.6.2 Amgen Personalized Medicine for Cancer Product Offered
- 11.6.3 Amgen Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Amgen Main Business Overview
- 11.6.5 Amgen Latest Developments
- 11.7 Merck
- 11.7.1 Merck Company Information
- 11.7.2 Merck Personalized Medicine for Cancer Product Offered
- 11.7.3 Merck Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Merck Main Business Overview
- 11.7.5 Merck Latest Developments
- 11.8 Bristol-Myers Squibb
- 11.8.1 Bristol-Myers Squibb Company Information
- 11.8.2 Bristol-Myers Squibb Personalized Medicine for Cancer Product Offered
- 11.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Bristol-Myers Squibb Main Business Overview
- 11.8.5 Bristol-Myers Squibb Latest Developments
- 11.9 Ariad Pharmaceuticals (Takeda)
- 11.9.1 Ariad Pharmaceuticals (Takeda) Company Information
- 11.9.2 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product Offered
- 11.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Ariad Pharmaceuticals (Takeda) Main Business Overview
- 11.9.5 Ariad Pharmaceuticals (Takeda) Latest Developments
- 11.10 Eli Lilly
- 11.10.1 Eli Lilly Company Information
- 11.10.2 Eli Lilly Personalized Medicine for Cancer Product Offered
- 11.10.3 Eli Lilly Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Eli Lilly Main Business Overview
- 11.10.5 Eli Lilly Latest Developments
- 11.11 Roche
- 11.11.1 Roche Company Information
- 11.11.2 Roche Personalized Medicine for Cancer Product Offered
- 11.11.3 Roche Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Roche Main Business Overview
- 11.11.5 Roche Latest Developments
- 11.12 Boehringer Ingelheim
- 11.12.1 Boehringer Ingelheim Company Information
- 11.12.2 Boehringer Ingelheim Personalized Medicine for Cancer Product Offered
- 11.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Boehringer Ingelheim Main Business Overview
- 11.12.5 Boehringer Ingelheim Latest Developments
- 11.13 Johnson and Johnson
- 11.13.1 Johnson and Johnson Company Information
- 11.13.2 Johnson and Johnson Personalized Medicine for Cancer Product Offered
- 11.13.3 Johnson and Johnson Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Johnson and Johnson Main Business Overview
- 11.13.5 Johnson and Johnson Latest Developments
- 11.14 Teva Pharmaceuticals
- 11.14.1 Teva Pharmaceuticals Company Information
- 11.14.2 Teva Pharmaceuticals Personalized Medicine for Cancer Product Offered
- 11.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Teva Pharmaceuticals Main Business Overview
- 11.14.5 Teva Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Personalized Medicine for Cancer. Industry analysis & Market Report on Personalized Medicine for Cancer is a syndicated market report, published as Global Personalized Medicine for Cancer Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Personalized Medicine for Cancer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
